» Articles » PMID: 37006188

IPMN-LEARN: A Linear Support Vector Machine Learning Model for Predicting Low-grade Intraductal Papillary Mucinous Neoplasms

Abstract

Backgrounds/aims: We aimed to build a machine learning tool to help predict low-grade intraductal papillary mucinous neoplasms (IPMNs) in order to avoid unnecessary surgical resection. IPMNs are precursors to pancreatic cancer. Surgical resection remains the only recognized treatment for IPMNs yet carries some risks of morbidity and potential mortality. Existing clinical guidelines are imperfect in distinguishing low-risk cysts from high-risk cysts that warrant resection.

Methods: We built a linear support vector machine (SVM) learning model using a prospectively maintained surgical database of patients with resected IPMNs. Input variables included 18 demographic, clinical, and imaging characteristics. The outcome variable was the presence of low-grade or high-grade IPMN based on post-operative pathology results. Data were divided into a training/validation set and a testing set at a ratio of 4:1. Receiver operating characteristics analysis was used to assess classification performance.

Results: A total of 575 patients with resected IPMNs were identified. Of them, 53.4% had low-grade disease on final pathology. After classifier training and testing, a linear SVM-based model (IPMN-LEARN) was applied on the validation set. It achieved an accuracy of 77.4%, with a positive predictive value of 83%, a specificity of 72%, and a sensitivity of 83% in predicting low-grade disease in patients with IPMN. The model predicted low-grade lesions with an area under the curve of 0.82.

Conclusions: A linear SVM learning model can identify low-grade IPMNs with good sensitivity and specificity. It may be used as a complement to existing guidelines to identify patients who could avoid unnecessary surgical resection.

Citing Articles

Pancreatic Ductal Adenocarcinoma (PDAC): A Review of Recent Advancements Enabled by Artificial Intelligence.

Mukund A, Afridi M, Karolak A, Park M, Permuth J, Rasool G Cancers (Basel). 2024; 16(12).

PMID: 38927945 PMC: 11201559. DOI: 10.3390/cancers16122240.


Early detection of pancreatic cancer in the era of precision medicine.

Ahmed T, Kawamoto S, Lopez-Ramirez F, Yasrab M, Hruban R, Fishman E Abdom Radiol (NY). 2024; 49(10):3559-3573.

PMID: 38761272 DOI: 10.1007/s00261-024-04358-w.


Improving Pancreatic Cyst Management: Artificial Intelligence-Powered Prediction of Advanced Neoplasms through Endoscopic Ultrasound-Guided Confocal Endomicroscopy.

Jiang J, Chao W, Cao T, Culp S, Napoleon B, El-Dika S Biomimetics (Basel). 2023; 8(6).

PMID: 37887627 PMC: 10604893. DOI: 10.3390/biomimetics8060496.

References
1.
Laffan T, Horton K, Klein A, Berlanstein B, Siegelman S, Kawamoto S . Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol. 2008; 191(3):802-7. PMC: 2692243. DOI: 10.2214/AJR.07.3340. View

2.
Vege S, Ziring B, Jain R, Moayyedi P . American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015; 148(4):819-22. DOI: 10.1053/j.gastro.2015.01.015. View

3.
Jovic S, Miljkovic M, Ivanovic M, Saranovic M, Arsic M . Prostate Cancer Probability Prediction By Machine Learning Technique. Cancer Invest. 2017; 35(10):647-651. DOI: 10.1080/07357907.2017.1406496. View

4.
Amato E, Dal Molin M, Mafficini A, Yu J, Malleo G, Rusev B . Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol. 2014; 233(3):217-27. PMC: 4057302. DOI: 10.1002/path.4344. View

5.
Elta G, Enestvedt B, Sauer B, Lennon A . ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts. Am J Gastroenterol. 2018; 113(4):464-479. DOI: 10.1038/ajg.2018.14. View